Arizona State Retirement System Global Blood Therapeutics, Inc. Transaction History

Arizona State Retirement System

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$32.4 - $68.18 $3,823 - $8,045	118 Added 0.71%	16,806 $1.14 Million
Q2 2022 Jul 28, 2022	BUY	$22.3 - $37.39 $22,523 - $37,763	1,010 Added 6.44%	16,688 $533,000
Q1 2022 May 04, 2022	BUY	$25.68 - $35.59 $14,380 - $19,930	560 Added 3.7%	15,678 $543,000
Q4 2021 Feb 04, 2022	SELL	$24.9 - $40.26 $3,660 - $5,918	-147 Reduced 0.96%	15,118 $443,000
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $1,503 - $2,203	59 Added 0.39%	15,265 $389,000
Q2 2021 Aug 02, 2021	SELL	$32.46 - $43.42 $31,940 - $42,725	-984 Reduced 6.08%	15,206 $533,000
Q1 2021 May 06, 2021	BUY	$38.94 - $50.85 $6,775 - $8,847	174 Added 1.09%	16,190 $660,000
Q4 2020 Jan 28, 2021	SELL	$37.65 - $63.77 $20,067 - $33,989	-533 Reduced 3.22%	16,016 $694,000
Q3 2020 Nov 05, 2020	BUY	$52.76 - $74.49 $221,169 - $312,262	4,192 Added 33.92%	16,549 $913,000
Q2 2020 Aug 04, 2020	SELL	$48.73 - $81.82 $86,885 - $145,885	-1,783 Reduced 12.61%	12,357 $780,000
Q1 2020 May 05, 2020	BUY	$41.72 - $87.2 $589,920 - $1.23 Million	14,140 New	14,140 $722,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.